More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.

A triglyceride-cutting drug from Ionis Pharmaceuticals proved so effective in a trial reported this past weekend that the biotech’s shares jumped more than 30%. Other news at the European Society of Cardiology Congress featured an AstraZeneca pill that the company thinks will become the best treatment for hard-to-control high blood pressure. Merck offered a hint about a new cholesterol treatment, saying the long-awaited pill for lowering cholesterol achieved “meaningful” reductions in a Phase 3 trial.

Continue Reading

View Comments